{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:29:51Z","timestamp":1792049391747,"version":"4.4.0"},"reference-count":24,"publisher":"Gobierno de Navarra","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An Sist Sanit Navar"],"published-print":{"date-parts":[[2018,4,30]]},"DOI":"10.23938\/assn.0125","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T09:50:21Z","timestamp":1516701021000},"page":"17-26","source":"Crossref","is-referenced-by-count":13,"title":["Uncomplicated urinary tract infections. Antimicrobial susceptibility study in Navarre"],"prefix":"10.23938","volume":"41","member":"10024","reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4321\/S1137-66272006000100003","article-title":"Etiolog\u00eda y sensibilidad antibi\u00f3tica de las infecciones extrahospitalarias m\u00e1s frecuentes","volume":"29","author":"MART\u00cdN SALAS","year":"2006","unstructured":"1. MART\u00cdN SALAS C, GIL-SETAS A, MAZ\u00d3N A. Etiolog\u00eda y sensibilidad antibi\u00f3tica de las infecciones extrahospitalarias m\u00e1s frecuentes. An Sist Sanit Navar 2006; 29: 27-36.","journal-title":"An Sist Sanit Navar"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/14787210.2016.1188004","article-title":"Tackling antimicrobial resistance in lower urinary tract infections: treatment options","volume":"14","author":"PITOUT","year":"2016","unstructured":"2. PITOUT JD, CHAN WW, CHURCH DL. Tackling antimicrobial resistance in lower urinary tract infections: treatment options. Expert Rev Anti Infect Ther 2016; 14: 621-632.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.medcli.2010.02.042","article-title":"Etiology and sensitivity of uropathogens identified in uncomplicated lower urinary tract infections in women (ARESC Study): implications on empiric therapy","volume":"136","author":"PALOU","year":"2011","unstructured":"3. PALOU J, PIGRAU C, MOLINA I, LEDESMA JM, ANGULO J, GRUPO COLABORADOR ESPA\u00d1OL DEL ESTUDIO ARESC. Etiology and sensitivity of uropathogens identified in uncomplicated lower urinary tract infections in women (ARESC Study): implications on empiric therapy. Med Clin (Barc) 2011; 136: 1-7.","journal-title":"Med Clin (Barc)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ajic.2014.06.013","article-title":"Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: A 7-year surveillance study","volume":"42","author":"SORLOZANO","year":"2014","unstructured":"4. SORLOZANO A, JIMENEZ-PACHECO A, DE DIOS LUNA DEL CASTILLO J, SAMPEDRO A, MARTINEZ-BROCAL A, MIRANDA-CASAS C et al. Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: A 7-year surveillance study. Am J Infect Control 2014; 42: 1033-1038.","journal-title":"Am J Infect Control"},{"key":"ref4","unstructured":"5. HORCAJADA JP, SORLI L, MONTERO M. Tratamiento de las infecciones no complicadas del tracto urinario inferior. Tratamiento de la pielonefritis aguda. En: Pigrau C, editor. Infecci\u00f3n del tracto urinario. Madrid: Salvat, 2013; 57-72."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. ANDREU DOMINGO A, CACHO J, COIRA NIETO A, LEPE JIM\u00c9NEZ JA. Diagn\u00f3stico microbiol\u00f3gico de las infecciones del tracto urinario. Procedimientos en Microbiolog\u00eda Cl\u00ednica. 2010.","DOI":"10.1016\/j.eimc.2010.06.008"},{"key":"ref6","unstructured":"https:\/\/www.seimc.org\/contenidos\/documentoscientificos\/procedimientosmicrobiologia\/seimc-procedimientomicrobiologia14a.pdf Consultado el 10 de noviembre de 2017"},{"key":"ref7","unstructured":"7. CLINICAL AND LABORATORY STANDARDS INSTITUTE. Performance standards for antimicrobial susceptibility testing; Twenty-fourth informational supplement (M100 S24). Wayne: Clinical and Laboratory Standards Institute; 2014."},{"key":"ref8","unstructured":"8. TENA D, GONZ\u00c1LEZ-PRAETORIUS A, GONZ\u00c1LEZ JC, HEREDERO E, ILLESCAS S, DE BARANDA CS et al. Changes in the antimicrobial susceptibility of Escherichia coli isolates from community diagnosed urinary tract infections during the period 2003-2007. Multicentre study in Castilla la Mancha (Spain). Rev Esp Quimioter 2010; 23: 36-42."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"9. GUPTA K, HOOTON TM, NABER KG, WULLT B, COLGAN R, MILLER LG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52: e103-120.","DOI":"10.1093\/cid\/ciq257"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1302186","article-title":"Voided midstream urine culture and acute cystitis in premenopausal women","volume":"369","author":"HOOTON","year":"2013","unstructured":"10. HOOTON TM, ROBERTS PL, COX ME, STAPLETON AE. Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med. 2013; 369: 1883-1891.","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1157\/13119488","article-title":"Etiology of community-acquired lower urinary infections and antimicrobial resistance of Escherichia coli: a national surveillance study","volume":"130","author":"ANDREU","year":"2008","unstructured":"11. ANDREU A, PLANELLS I. Etiology of community-acquired lower urinary infections and antimicrobial resistance of Escherichia coli: a national surveillance study. Med Clin (Barc) 2008; 130: 481-486.","journal-title":"Med Clin (Barc)"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"12. FASUGBA O, MITCHELL BG, MNATZAGANIAN G, DAS A, COLLIGNON P, GARDNER A. Five-year antimicrobial resistance patterns of urinary Escherichia coli at an Australian tertiary hospital: time series analyses of prevalence data. PLoS One. 2016; 11: e0164306.","DOI":"10.1371\/journal.pone.0164306"},{"key":"ref13","unstructured":"13. TREVI\u00d1O M, LOSADA I, FERN\u00c1NDEZ-P\u00c9REZ B, COIRA A, PE\u00d1A-RODR\u00cdGUEZ MF, HERVADA X. Surveillance of antimicrobial susceptibility of Escherichia coli producing urinary tract infections in Galicia (Spain). Rev Esp Quimioter 2016; 29: 86-90."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3201\/eid1411.070467","article-title":"Antimicrobial drug use and resistance in Europe","volume":"14","author":"VAN DE SANDE-BRUINSMA","year":"2008","unstructured":"14. VAN DE SANDE-BRUINSMA N, GRUNDMANN H, VERLOO D, TIEMERSMA E, MONEN J, GOOSSENS H et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008; 14: 1722-1730.","journal-title":"Emerg Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ijantimicag.2009.04.012","article-title":"The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections","volume":"34","author":"SCHITO","year":"2009","unstructured":"15. SCHITO GC, NABER KG, BOTTO H, PALOU J, MAZZEI T, GUALCO L et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009; 34: 407-413.","journal-title":"Int J Antimicrob Agents"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"16. BRYCE A, HAY AD, LANE IF, THORNTON HV, WOOTTON M, COSTELLOE C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ. 2016; 352 :i939.","DOI":"10.1136\/bmj.i939"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1157\/13073144","article-title":"Changes in the antimicrobial susceptibility of Escherichia coli isolates from nosocomial versus community-acquired urinary tract infections","volume":"23","author":"JUNQUERA","year":"2005","unstructured":"17. JUNQUERA S, LOZA E, BAQUERO F. Changes in the antimicrobial susceptibility of Escherichia coli isolates from nosocomial versus community-acquired urinary tract infections. Enferm Infecc Microbiol Clin 2005; 23:197-201.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2334-13-19","article-title":"Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009)","volume":"13","author":"LINHARES","year":"2013","unstructured":"18. LINHARES I, RAPOSO T, RODRIGUES A, ALMEIDA A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis 2013; 13: 19.","journal-title":"BMC Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jmii.2012.05.012","article-title":"Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005-2010","volume":"46","author":"MARAKI","year":"2013","unstructured":"19. MARAKI S, MANTADAKIS E, MICHAILIDIS L, SAMONIS G. Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005-2010. J Microbiol Immunol Infect 2013; 46: 202-209.","journal-title":"J Microbiol Immunol Infect"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.eururo.2008.05.010","article-title":"Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy","volume":"54","author":"NABER","year":"2008","unstructured":"20. NABER KG, SCHITO G, BOTTO H, PALOU J, MAZZEI T. Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur Urol 2008; 54: 1164-1175.","journal-title":"Eur Urol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.pop.2008.01.001","article-title":"Urinary tract infections","volume":"35","author":"DM","year":"2008","unstructured":"21. DREKONJA DM, JOHNSON JR. Urinary tract infections. Prim Care 2008; 35: 345-367.","journal-title":"Prim Care"},{"key":"ref22","unstructured":"22. AGENCIA ESPA\u00d1OLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS. Nitrofurantoina (Furantoina\u00ae): Nuevas restricciones de uso. http:\/\/www.aemps.gob.es Consultado el 10 de septiembre de 2017."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"7019","DOI":"10.1128\/AAC.03946-14","article-title":"In vitro activity of nitroxoline against Escherichia coli urine isolates from outpatients departments in Germany","volume":"58","author":"KRESKEN","year":"2014","unstructured":"23. KRESKEN M, K\u00d6RBER-IRRGANG B. In vitro activity of nitroxoline against Escherichia coli urine isolates from outpatients departments in Germany. Antimicrob Agents Chemother 2014; 58: 7019-7020.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Anales del Sistema Sanitario de Navarra"],"original-title":[],"link":[{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/59989\/39296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:32:34Z","timestamp":1749558754000},"score":1,"resource":{"primary":{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/59989\/39296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,30]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,4]]}},"URL":"https:\/\/doi.org\/10.23938\/assn.0125","relation":{},"ISSN":["1137-6627"],"issn-type":[{"value":"1137-6627","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4,30]]}}}